Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, i⦠read more
Healthcare
Biotechnology
1 years
USD
Exclusive to Premium users
$6.15
Price-0.57%
-$0.03
$381.727m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$1.238m
-
1y CAGR-
3y CAGR-
5y CAGR-$101.378m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.96
-
1y CAGR-
3y CAGR-
5y CAGR$174.629m
$204.397m
Assets$29.768m
Liabilities$18.112m
Debt8.9%
-0.2x
Debt to EBITDA-$84.220m
-
1y CAGR-
3y CAGR-
5y CAGR